Organ Preservation Market Outlook Report 2025-2030: University of Wisconsin Solution Leads the Way in Organ Preservation with Largest Market Share

The global organ preservation market is set to elevate from USD 0.2 billion in 2025 to USD 0.3 billion by 2030, with a CAGR of 6.8%. This growth is driven by increasing global organ transplants, advancements in preservation techniques, and rising chronic disease incidences. The University of Wisconsin (UW) solution dominated the market in 2024. Normothermic machine perfusion is projected for the highest technique growth, enhancing liver transplant outcomes, while the lungs segment and specialty clinics anticipate significant growth. The Asia Pacific region leads in CAGR, bolstered by robust healthcare advancements and policies. Major players include Paragonix Technologies, XVIVO Perfusion, and TransMedics.


Dublin, Aug. 18, 2025 (GLOBE NEWSWIRE) -- The "Organ Preservation Market by Solution Type (UW, Custodial HTK, Perfadex), Technique (Static Cold Storage, Hypothermic, Normothermic), Organ (Kidneys, Liver, Heart), End User (Transplant Centers, Hospitals, Specialty Clinics) - Global Forecast to 2030" has been added to ResearchAndMarkets.com's offering.

The global organ preservation market is anticipated to expand, reaching USD 0.3 billion by 2030, up from USD 0.2 million in 2025, at a CAGR of 6.8%.

Key market drivers include rising global organ transplant rates, advancements in preservation technologies, and the introduction of advanced solutions like hypothermic and normothermic machine perfusion systems. The prevalence of chronic diseases like end-stage renal and liver failure further strengthens the demand for organ transplants, consequently boosting the need for effective preservation technologies.

University of Wisconsin (UW) Solution Leads Market Share in 2024

The solution type segment is dominated by the University of Wisconsin (UW) solution, capturing the largest market share in 2024. This is attributed to its high adoption and proven effectiveness in preserving organs such as the liver, kidneys, and pancreas. The UW solution, celebrated for its reliable clinical outcomes, is the preferred choice among transplant surgeons and healthcare facilities worldwide.

Normothermic Machine Perfusion to Record Highest CAGR

The normothermic machine perfusion technique is projected to achieve the highest CAGR during the forecast period. By maintaining normal body temperature and supplying essential nutrients and oxygen, it supports cellular functions and metabolism, reducing inflammatory responses and ischemic injury. This technique is crucial in liver transplants, particularly among extended criteria donors, promoting improved graft regeneration and better long-term outcomes.

Lungs Segment Poised for Rapid Growth

The lungs segment is projected to accelerate at the highest CAGR during the forecast period. Lung transplants-essential for treating end-stage lung diseases such as COPD, idiopathic pulmonary fibrosis, and cystic fibrosis-are on the rise due to the increasing prevalence of respiratory illnesses. Technological advancements improving graft survival and function have solidified lung transplants as a critical therapeutic option.

Specialty Clinics Segment to Experience Growth Surge

Among end-users, specialty clinics are expected to register the highest CAGR. These clinics are gaining prominence in transplant procedures and post-operative care, offering specialized expertise, rapid turnaround times, and cutting-edge technologies. The growing patient preference for specialized care and increased private healthcare investments further propel market growth.

Asia Pacific Region to Lead in Growth

The Asia Pacific region is set to lead the growth chart, fueled by favorable government policies, public awareness efforts, and increased organ donation rates. Noteworthy developments include China's improved donation rates due to educational and mobilization efforts, and India's burgeoning healthcare infrastructure promoting medical tourism. Despite cultural challenges, Japan is seeing a rise in willingness to donate organs.

Market Participant Breakdown

  • By Company Type: Tier 1 - 35%, Tier 2 - 45%, Tier 3 - 20%
  • By Designation: C-level - 35%, Director-level - 25%, Others - 40%
  • By Region: North America - 45%, Europe - 30%, Asia Pacific - 20%, Latin America - 3%, Middle East & Africa - 1%, GCC countries - 1%

Key Players in Organ Preservation Market

Leading players include Paragonix Technologies, XVIVO Perfusion AB, Dr. Franz Kohler Chemie GmbH, Essential Pharmaceuticals, TransMedics, OrganOx Limited, 21st Century Medicine, Shanghai Genext Medical Technology, Bridge to Life Limited, and others. Each company is crucial to the innovations and competitive strategies shaping the future of organ preservation.

Research Coverage and Strategic Insights

This report delves into the organ preservation market, estimating market size and growth potential across solution, technique, organ type, end user, and region segments. It presents an exhaustive examination of key players, their offerings, and strategic initiatives, providing actionable insights for firms seeking a competitive edge.

Key Attributes:

Report AttributeDetails
No. of Pages235
Forecast Period2025 - 2030
Estimated Market Value (USD) in 2025$0.2 billion
Forecasted Market Value (USD) by 2030$0.3 million
Compound Annual Growth Rate6.8%
Regions CoveredGlobal



Key Topics Covered:

Market Dynamics

  • Drivers
    • Growing Geriatric Population and Subsequent Growth in Cases of Multiple Organ Failure
    • Increasing Initiatives to Promote Public Awareness and Encourage Organ Donation
    • Rising Number of Organ Donors and Growing Adoption of Solid Organ Transplantation Procedures
  • Challenges
    • High Cost of Organ Transplantation
    • Religious Concerns and Misconceptions Associated with Organ Donation
  • Opportunities
    • Growing Healthcare Investments
  • Challenges
    • Significant Gap Between Number of Organs Donated and Organs Required Annually
    • Development of Artificial Organs
  • Case Studies
  • Industry Trends

Company Profiles

  • Paragonix Technologies, Inc.
  • Xvivo Perfusion Ab
  • Dr. Franz Kohler Chemie GmbH
  • Essential Pharmaceuticals, LLC (Subsidiary of Accord Healthcare)
  • Transmedics, Inc.
  • Organox Limited
  • 21St Century Medicine
  • Biolife Solutions, Inc.
  • Bridge to Life Limited
  • Waters Medical Systems LLC
  • Shanghai Genext Medical Technology Co., Ltd.
  • Preservation Solutions, Inc.
  • Carnamedica
  • Transplant Biomedicals
  • Institut Georges Lopez
  • Global Transplant Solutions
  • Avionord
  • Organ Preservation Solutions Ltd.
  • Ebers
  • S.A.L.F.
  • Biochefa
  • Vascular Perfusion Solutions, Inc.
  • Tx Innovations
  • Taiyo Nippon Sanso Corporation
  • X-Therma, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/2jj4cd

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

 
Global Organ Preservation Market

Contact Data

Recommended Reading